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Measuring expression of thousends of genes
Target DNA sequence





Measuring expression of thousends of genes

















Differences in gene expression
• Ratio cut-off (two fold regulation)
• Two sample t-test per gene
















Performance of various methods
on a known micro array dataset* 




Aim: learn about stem cell differentiation and 
bone formation
• human mesenchymal stem cells
• three treatments (DEX, BMP, VIT), one control





eleven time points (incl. t = 0)
• time points close together in the beginning
• three replicate measurements
• data hypercube of dimensions 22283 x 3 x 11 x 4





Assume factors Treatment (T), Time (S) and Gene (G):
fixed-effect model
Xijkr = 
+ Ti + Sj + Gk
+ (TS)ij + (TG)ik + (SG)jk
+ (TSG)ijk
+ ε ijkr
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fixed-effect model
Xijkr = 
+ Ti + Sj + Gk
+ (TS)ij + (TG)ik + (SG)jk
+ (TSG)ijk
+ ε ijkr
Interaction matrices contain interesting information













PCA on the ANOVA interaction matrix
J. de Haan et al., Bioinformatics 23, 184-190 (2007)
H. F. Gollob, Psychometrika, 33, 73–114 (1968)
































Based on Hotelling T2 ( α= 10−5): 384 genes selected
Gene selection




Validation of gene selection
Step 1: agreement with “known” biology


















For every GO category (of interest):
• Estimate the expected number of genes in that category
• Calculate a p value for finding as many genes as you do
(hypergeometric test, 2-test, z-scores, ...)
Caveats:
• Critical level for gene selection? 
• Multiple testing correction?







• GO:0048513 organ development
• GO:0009653 morphogenesis
• GO:0001501 skeletal development
• GO:0001568 blood vessel development
• GO:0001944 vasculature development
• GO:0048514 blood vessel morphogenesis






Enrichment across several thresholds (T2)




Plotting enrichment information in the GO tree





When is an enrichment significant? (p-value)




When is an enrichment significant? Check 30 GO terms known to be involved
957 genes ( T2  α = 10−2)




30 random processes (A) or random genes (B)









Number of enriched (expected) processes




Validation of gene selection







Average GxTxS interaction effect
ANOVA on selected genes (384)
Vitamine D : shift in kinetics*




Based on Hotelling T2 ( α= 10−5): 384 genes selected
Gene selection : based on ANOVA-PCA
ANOVA : Normal distribution !





Non parametric ANOVA - PCA
• Robust location (RL) : Mean  → Median
• Rank transformation (RT): data → ranks →ANOVA














PCA on the ANOVA interaction matrix
Gene x Treatment (22283 x 4)




Check 30 GO terms known to be involved






• Distribution of the differences 
classical – rotated robust method
• Overall procrustes error: Σ (classical – rotated)2
• PCA on difference matrix 
Classical ANOVA-PCA    vs robust ANOVA-PCA




Procrustes analysis : 
Distribution of differences






Rank Transform +CL 96.0
Aligned Rank Transform +CL 96.4
Procrustes analyses :
Overall Procrustes error




Procrustes analysis: PCA on difference matrix
RL vs CL RT+CL vs CL





• Individual variance terms (from ANOVA) can be very informative;
• Useful for gene selection, too
• Non-parametric ANOVA even better (manuscr. submitted)
• GO information is essential for biological validation: 
• Lack of annotation is a problem
Supplementary material available from http://www.cac.science.ru.nl
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